About Xiamen Manteia Technology
Manteia Technologies is a technology-driven company specializing in vendor-independent radiation therapy software for cancer treatment. Founded in 2017 in Xiamen, China, the company originated from the Adaptive Research Group in the U.S., with a team of experienced physicians and medical physicists from clinical backgrounds. Manteia's comprehensive radiation oncology solution encompasses image-based treatment planning, quality assurance and quality control (QA/QC), and Adaptive Radiation Therapy (ART). Their product suite includes AccuContour for AI-powered contouring, AccuLearning as a deep learning training platform, Mozi TPS for next-generation treatment planning, and Monte Carlo-based QA solutions for patient QA and machine QC. The company's fully interoperable system integrates seamlessly into existing clinical workflows, enhancing treatment accuracy and adaptability. Manteia serves radiation oncology departments, medical physics teams, and cancer treatment centers globally, with recent deployments including Responsible Research Hospital in Italy. Their mission is to celebrate life with technologies by developing intelligent, adaptive, and precision-driven solutions that enhance cancer care and improve patient outcomes.
Mission & Story
Mission
Celebrate Life with Technologies. We envision a future where innovation enhances care and improves lives.
Founding Story
Founded in 2017 in Xiamen, China, Manteia originated from the Adaptive Research Group in the U.S. The founding team includes experienced physicians and medical physicists from clinical backgrounds, dedicated to developing intelligent, adaptive, and precision-driven solutions for cancer treatment.
Clinical Focus
Medical conditions and clinical areas addressed by Xiamen Manteia Technology.
Who It Serves
Milestones & Awards
Recent Milestones
Launch of Online Adaptive Radiotherapy (oART) at Responsible Research Hospital in Italy powered by Mozi TPS (2025). New official website launch featuring flagship products (April 2025). Italian media coverage describing deployment as 'Epochal Turning Point' and entry into Radiotherapy 4.0 era.
Key Partnerships
Company Details
- Founded
- 2017
- Headquarters
- Xiamen, Fujian, China
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingMarket
Surgical AI & RoboticsOfficial Sources
Similar Companies in this Market
View all 58 →
3D-Side
AI-powered 3D preoperative planning and patient-specific medical devices for surgical workflow optimization and planning.
Activ Surgical
series b · 40 employees
Activ Surgical provides intraoperative surgical intelligence enabling surgeons to view critical physiological structures and functions in real-time.
AIbolit Technologies
Aibolit Technologies (Aibo Health) provides an AI- and AR-powered perioperative digital platform that optimizes operating room workflows, enhances surgical quality, and improves training for nurses, surgeons, and OR managers across hospitals and ambulatory surgery centers.
Asensus Surgical
Asensus Surgical develops robotic-assisted surgical systems integrated with Augmented Intelligence to provide real-time insights during minimally invasive procedures. The company's Senhance® Surgical System and Intelligent Surgical Unit™ deliver data-driven decision support to surgeons, enhancing precision, efficiency, and patient outcomes.
Augmedics
Augmedics develops augmented reality surgical navigation technology for spine surgery. Their xvision Spine System provides surgeons with x-ray vision through AR headsets, enabling them to visualize patient anatomy in 3D during procedures without looking away at screens.
Augmedit
11-50 employees
Augmedit develops augmented reality medical software that guides surgeons through complex procedures using 3D holograms generated from medical imaging. The company's platform converts 2D DICOM images into interactive 3D models for surgical planning, patient education, and intra-operative visualization.
Brainlab
Brainlab develops hardware and software technology for surgery and radiation therapy to help healthcare providers, physicians and their patients fight cancer and other conditions of the brain and body.
Caranx Medical
Caranx Medical develops surgical AI and robotics solutions for healthcare providers. The company focuses on advancing surgical precision and outcomes through innovative technology platforms.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.